Asia-Pacific markets set to open lower after Wall Street declines

Asia-Pacific markets set to open lower after Wall Street declines


People

Maydays | Moment | Getty Images

Asia-Pacific markets were poised to open lower Tuesday, tracking losses on Wall Street, with investors awaiting a key U.S. inflation report for clarity on the Federal Reserve’s rate-cut path.

Investors will also assess the meeting between South Korean and U.S. presidents over fleshing out the trade deal framework announced last month that stipulated 15% tariffs on the Asian country’s exports to the U.S.

Japan’s Nikkei 225 was set to open lower, with the futures contract in Chicago at 42,670 while its counterpart in Osaka last traded at 42,530, against the index’s Monday close of 42,807.82.

Australia’s S&P/ASX 200 was set to start the day lower, with futures tied to the benchmark at 8,930, compared with the index’s last close of 8,972.40.

Futures for Hong Kong’s Hang Seng index stood at 25,711, pointing to a weaker open compared with the HSI’s last close of 25,829.91

China stocks will be in focus, after the mainland’s CSI 300 extended its gains for a fourth straight session, climbing more than 2% on Monday.

Shares in the Nasdaq Golden Dragon China Index — which captures Chinese stocks listed on the U.S. — ended Monday’s session higher despite losses in the key benchmarks on Wall Street.

U.S. equity futures were little changed in early Asia hours, as investors await Nvidia‘s earnings and reading of the U.S. Federal Reserve’s preferred inflation gauge.

Overnight stateside, all three key benchmarks fell with the tech-heavy Nasdaq down 0.22% at 21,449.29. The broad market S&P 500 traded 0.43% lower to settle at 6,439.32, while the 30-stock Dow Jones Industrial Average closed down 349.27 points, or 0.77%, at 45,282.47.

— CNBC’s Sean Conlon and Tanaya Macheel contributed to this report.



Source

Nine of the largest pharma companies ink deals with Trump to lower drug prices
World

Nine of the largest pharma companies ink deals with Trump to lower drug prices

President Donald Trump signs an executive order aimed at reducing the cost of prescription drugs and pharmaceuticals by 30% to 80% during an event in the Roosevelt Room of the White House on May 12, 2025, in Washington, DC. Andrew Harnik | Getty Images Several of the largest U.S. and European-based drugmakers inked deals with […]

Read More
Google’s boomerang year: 20% of AI software engineers hired in 2025 were ex-employees
World

Google’s boomerang year: 20% of AI software engineers hired in 2025 were ex-employees

Sundar Pichai, chief executive officer of Alphabet Inc., during the Bloomberg Tech conference in San Francisco, California, US, on Wednesday, June 4, 2025. David Paul Morris | Bloomberg | Getty Images With the AI talent wars heating up between companies like OpenAI, Meta and Anthropic, one way Google has been competing is by aggressively rehiring […]

Read More
Claire’s new owner Ames Watson feuds with Asia-based suppliers over millions in unpaid debt
World

Claire’s new owner Ames Watson feuds with Asia-based suppliers over millions in unpaid debt

Chris Ratcliffe | Bloomberg | Getty Images Tween retailer Claire’s is facing legal challenges from some of its Asia-based suppliers over millions in unpaid debts as it tries to emerge from a second bankruptcy under new ownership, according to claims the suppliers filed in Hong Kong.  The clash with vendors comes as private equity firm […]

Read More